Bile duct ligation in mice: Induction of inflammatory liver injury and fibrosis by obstructive cholestasis

Journal of Visualized Experiments

Volumn , Issue 96, 2015, Pages

  Tag, Carmen G ^a   Sauer Lehnen, Sibille ^a   Weiskirchen, Sabine ^a   Borkham Kamphorst, Erawan ^a   Tolba, René H ^a   Tacke, Frank ^a   Weiskirchen, Ralf ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Bile duct ligation; Bile obstruction; Cholestasis; Extracellular matrix; Hepatic fibrosis; Inflammation; Issue 96; Jaundice; Medicine; Mouse

Indexed keywords

ANIMAL; C57BL MOUSE; CHOLESTASIS; COMMON BILE DUCT; DISEASE MODEL; HEPATITIS; LIGATION; LIVER CIRRHOSIS; MALE; MOUSE; PATHOLOGY; PROCEDURES; SURGERY;

ANIMALS; CHOLESTASIS; COMMON BILE DUCT; DISEASE MODELS, ANIMAL; HEPATITIS; LIGATION; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL;

EID: 84923534792     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/52438     Document Type: Article

References (27)

1. Liedtke, C., et al. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenesis Tissue Repair. 6, (1), 19 (2013).
2. Aller, M. A., Arias, J. L., García-Domínguez, J., Arias, J. I., Durán, M., Arias, J. Experimental obstructive cholestasis: the wound-like inflammatory liver response. Fibrogenesis Tissue Repair. 1, (1), 6 (2008).
3. Tacke, F., Weiskirchen, R. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol. 6, (1), 67-80 (2012).
4. Weiler-Normann, C., Herkel, J., Lohse, A. W. Mouse models of liver fibrosis. Z. Gastroenterol. 45, (1), 43-50 (2007).
5. Cameron, G. R., Oakley, C. L. Ligation of the common bile duct. J. Pathol. 35, (5), 769-798 (1932).
6. Cameron, G. R., Hasan, S. M. Disturbances of structure and function in the liver as the result of biliary obstruction. J. Pathol. 75, (2), 333-349 (1958).
7. Accatino, L., Contreras, A., Fernańdez, S., Quintana, C. The effect of complete biliary obstruction on bile flow and bile acid excretion: postcholestatic choleresis in the rat. J Lab Clin Med. 93, (5), 706-717 (1979).
8. Accatino, L., Contreras, A., Berdichevsky, E., Quintana, C. The effect of complete biliary obstruction on bile secretion. Studies on the mechanisms of postcholestatic choleresis in the rat. J Lab Clin Med. 97, (4), 525-534 (1981).
9. Kountouras, J., Billing, B. H., Scheuer, P. J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 65, (3), 305-311 (1984).
10. Tuchweber, B., Desmoulière, A., Bochaton-Piallat, M. L., Rubbia-Brandt, L., Gabbiani, G. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest. 74, (1), 265-278 (1996).
11. Desmoulière, A., et al. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest. 76, (6), 765-778 (1997).
12. Arias, M., et al. Adenoviral expression of a transforming growth factor-β1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol. 3, (29), (2003).
13. Borkham-Kamphorst, E., et al. Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab. Invest. 84, (6), 766-777 (2004).
14. Borkham-Kamphorst, E., Huss, S., Van de Leur, E., Haas, U., Weiskirchen, R. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis. Liver Int. 32, (9), 1342-1353 (2012).
15. Borkham-Kamphorst, E., et al. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling. Biochim. Biophys. Acta. 1843, (5), 902-914 (2014).
16. Huss, S., et al. Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis. Fibrogenesis Tissue Repair. 3, (1), 10 (2010).
17. Borkham-Kamphorst, E., Drews, F., Weiskirchen, R. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation. Liver Int. 31, (5), 656-665 (2011).
18. Karlmark, K. R., et al. The fractalkine receptor CX3CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology. 52, (5), 1769-1782 (2010).
19. Tarcin, O., et al. Time course of collagen peak in bile duct-ligated rats. BMC Gastroenterol. 11, 45 (2011).
20. Takase, S., Leo, M. A., Nouchi, T., Lieber, C. S. Desmin distinguishes cultured fat-storing cells from myofibroblasts, smooth muscle cells and fibroblasts in the rat. J. Hepatol. 6, (3), 267-276 (1988).
21. Borkham-Kamphorst, E., et al. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis. Biochim. Biophys. Acta. 1832, (5), 660-673 (2013).
22. Labbus, K., et al. Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions. J Proteomics. 78, 188-196 (2013).
23. Kirkland, J. G., et al. Reversible surgical model of biliary inflammation and obstructive jaundice in mice. J. Surg. Res. 164, (2), 221-227 (2010).
24. Heinrich, S., et al. Partial bile duct ligation in mice: a novel model of acute cholestasis. Surgery. 149, (3), 445-451 (2011).
25. Scholten, D., et al. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology. 139, (3), 987-998 (2010).
26. Aller, M. A., et al. A half century (1961-2011) of applying microsurgery to experimental liver research. World J Hepatol. 4, (7), 199-208 (2012).
27. Russell, W. M. S., Burch, R. The Principles of Humane Experimental Technique. London, Methuen (1959).